0002038826-25-000002.txt : 20251008 0002038826-25-000002.hdr.sgml : 20251008 20251008090525 ACCESSION NUMBER: 0002038826-25-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251008 DATE AS OF CHANGE: 20251008 EFFECTIVENESS DATE: 20251008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bectas Therapeutics, Inc. CENTRAL INDEX KEY: 0002038826 ORGANIZATION NAME: EIN: 920728758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-526249 FILM NUMBER: 251381319 BUSINESS ADDRESS: STREET 1: 3262 WESTHEIMER ROAD STREET 2: SUITE 762 CITY: HOUSTON STATE: TX ZIP: 77098 BUSINESS PHONE: 617-834-3476 MAIL ADDRESS: STREET 1: 3262 WESTHEIMER ROAD STREET 2: SUITE 762 CITY: HOUSTON STATE: TX ZIP: 77098 D/A 1 primary_doc.xml X0708 D/A LIVE 0002038826 Bectas Therapeutics, Inc. 3262 WESTHEIMER ROAD SUITE 762 HOUSTON TX TEXAS 77098 617-834-3476 DELAWARE None None Corporation true 2022 Ronan O'Hagan 3262 Westheimer Road Suite 762 Houston TX TEXAS 77098 Executive Officer Director Lynda Chin 3262 Westheimer Road Suite 762 Houston TX TEXAS 77098 Director Jon A. Brilliant 3262 Westheimer Road Suite 762 Houston TX TEXAS 77098 Executive Officer Biotechnology Decline to Disclose 06b true 0002038826-24-000001 2022-10-21 false true false 0 10000000 5550000 4450000 false 13 0 0 0 false Bectas Therapeutics, Inc. /s/ Ronan O'Hagan Ronan O'Hagan President and CEO 2025-10-08